Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.
Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.
复制标题
DOI：
10.1136/annrheumdis-2012-202726
复制
发表时间：
2014-01
影响因子：
27.4
通讯作者：
Venables PJ
中科院分区：
文献类型：
--
作者：
Quirke AM;Lugli EB;Wegner N;Hamilton BC;Charles P;Chowdhury M;Ytterberg AJ;Zubarev RA;Potempa J;Culshaw S;Guo Y;Fisher BA;Thiele G;Mikuls TR;Venables PJ
Rheumatoid arthritis (RA) is characterised by autoimmunity to citrullinated proteins, and there is increasing epidemiologic evidence linking Porphyromonas gingivalis to RA. P gingivalis is apparently unique among periodontal pathogens in possessing a citrullinating enzyme, peptidylarginine deiminase (PPAD) with the potential to generate antigens driving the autoimmune response. To examine the immune response to PPAD in patients with RA, individuals with periodontitis (PD) and controls (without arthritis), confirm PPAD autocitrullination and identify the modified arginine residues. PPAD and an inactivated mutant (C351A) were cloned and expressed and autocitrullination of both examined by immunoblotting and mass spectrometry. ELISAs using PPAD, C351A and another P gingivalis protein arginine gingipain (RgpB) were developed and antibody reactivities examined in patients with RA (n=80), individuals with PD (n=44) and controls (n=82). Recombinant PPAD was a potent citrullinating enzyme. Antibodies to PPAD, but not to Rgp, were elevated in the RA sera (median 122 U/ml) compared with controls (median 70 U/ml; p<0.05) and PD (median 60 U/ml; p<0.01). Specificity of the anti-peptidyl citrullinated PPAD response was confirmed by the reaction of RA sera with multiple epitopes tested with synthetic citrullinated peptides spanning the PPAD molecule. The elevated antibody response to PPAD was abolished in RA sera if the C351A mutant was used on ELISA. The peptidyl citrulline-specific immune response to PPAD supports the hypothesis that, as a bacterial protein, it might break tolerance in RA, and could be a target for therapy.
登录
查看更多内容
影响因子：
--
作者：
Harris, Michelle L.;Darrah, Erika;Lam, Gordon K.;Bartlett, Susan J.;Giles, Jon T.;Grant, Audrey V.;Gao, Peisong;Scott, William W., Jr.;El-Gabalawy, Hani;Casciola-Rosen, Livia;Barnes, Kathleen C.;Bathon, Joan M.;Rosen, Antony
通讯作者：
Rosen, Antony
影响因子：
3.9
作者：
Rodríguez SB;Stitt BL;Ash DE
通讯作者：
Ash DE
影响因子：
--
作者：
Vossenaar, ER;Smeets, TJM;Tak, PP
通讯作者：
Tak, PP
影响因子：
5.6
作者：
Mikuls, Ted R.;Payne, Jeffrey B.;Reinhardt, Richard A.;Thiele, Geoffrey M.;Maziarz, Eileen;Cannella, Amy C.;Holers, V. Michael;Kuhn, Kristine A.;O'Dell, James R.
通讯作者：
O'Dell, James R.
影响因子：
--
作者：
Lundberg, Karin;Kinloch, Andrew;Venables, Patrick J.
通讯作者：
Venables, Patrick J.